Anzeige
Mehr »
Montag, 09.02.2026 - Börsentäglich über 12.000 News
Der Shakeout: Silber hat genau das getan, was echte Bullenmärkte immer tun - es hat die Touristen abgeschüttelt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
242 Leser
Artikel bewerten:
(1)

Clario Launches Cloud-Based Image Viewer for Clinical Trials

Image Viewer is a comprehensive, intuitive solution for clinical trial imaging needs, providing real-time, on-demand viewing and manipulation at high resolution

  • New Image Viewer Tool provides real-time on-demand images for clinical trials
  • Viewing and manipulating images taken during clinical trials was a complex and time-consuming process that now can be done simply using new cloud-based system
  • It is data privacy compliant, enabling easy electronic image accessibility, and all within a streamlined, fully integrated process and platform

PHILADELPHIA, March 13, 2023 /PRNewswire/ -- Clario, a healthcare research technology company that delivers the leading endpoint technology solutions for clinical trials, has launched a cutting-edge cloud-based Image Viewer tool for sponsors and CROs to view the images of their clinical trials.

Clario

Previously, to view images for a clinical trial, multiple groups were involved in the image transfer process, which added risk of delay and potential errors to an already complex process. Due to third-party access and allocation, most sponsors would have to wait until the end of the study phase or longer to view their images.

"At Clario we are committed to accelerate Clinical Trials by solving complex problems; and this world-class Image Viewer is a leap in that direction by providing powerful insights to Clients early on. The Cloud-native Image Viewer is an innovative tool incorporating advanced usability features and is custom built working closely with our in-house radiologists specifically for Clinical Trial needs," said Gaurav Josan, SVP R&D at Clario.

With the new Image Viewer tool, sponsors and CROs can access read-quality images in near real-time through an intuitive web-based imaging viewer. The tool streamlines the process and eliminates manual steps, making the image accessibility easy and secure. It provides viewing and manipulation tools for full-resolution, empowering the end users to gain valuable insights into their trial subjects. The tool is data privacy compliant, enabling easy electronic image accessibility, and all within a streamlined, fully integrated process and platform.

"We expect our Cloud-Based Image Viewer to greatly simplify and accelerate viewing images during clinical trials," said Brad Dean, EVP Medical Imaging at Clario. "We have a long history of innovation in medical imaging for clinical trials. This new offering is unmatched in the market, providing user-friendly image access minimizing cost, time and risk."

About Clario

Clario is a leading healthcare research and technology company that generates the richest clinical evidence in the industry for our pharmaceutical, biotech and medical device partners. Across decentralized, hybrid and site-based trials, our deep scientific expertise, global scale and the broadest endpoint technology platform in the industry allows our partners to transform lives. Clario has the only technology platform that combines eCOA, cardiac safety, medical imaging, precision motion, and respiratory endpoints. Clario's global team of science, technology and operational experts have helped deliver over 24,000 trials and contributed to over 500 FDA and EMEA new drug approvals involving more than five million patients in 120 countries. Our innovation has been transforming clinical trials for 50 years. For more information, visit Clario.com or follow us on LinkedIn and Twitter.

Contact:
Alexis Navratil
alexis.navratil@clario.com

Logo - https://mma.prnewswire.com/media/1677749/Clario_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/clario-launches-cloud-based-image-viewer-for-clinical-trials-301769295.html

© 2023 PR Newswire
Vorsicht, geheim!
2026 startet mit einem Paukenschlag: Der DAX outperformt den US-Markt, Nachzügler holen auf. Ein erstes Signal, dass der Bullenmarkt an Breite gewinnt. Während viele Anleger weiter auf die großen Tech-Namen setzen, hat sich im Hintergrund längst ein Umschwung vollzogen. Der Fokus verschiebt sich weg von überteuerten KI-Highflyern hin zu soliden Qualitätswerten aus der zweiten Reihe.

Anleger, die jetzt clever agieren, setzen nicht auf das, was war, sondern auf das, was kommt. Unternehmen mit gesunder Bilanz, unterschätztem Potenzial und begrenztem Abwärtsrisiko könnten 2026 zu den großen Gewinnern zählen. Die Gefahr einer schärferen Korrektur bleibt real, gerade für passiv aufgestellte Investoren.

In unserem neuen Spezialreport stellen wir fünf Aktien vor, die genau jetzt das Potenzial für überdurchschnittliche Renditen bieten. Stark, günstig und bislang kaum im Fokus.

Jetzt kostenlosen Report herunterladen – bevor es andere tun!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.